A Study to Evaluate the Safety and Tolerability of ABBV-0805 in Patients With Parkinson's Disease

NCT04127695 · clinicaltrials.gov ↗

PHASE1

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped Strategic considerations

Conditions

Parkinson's Disease

Interventions

DRUG: ABBV-0805
DRUG: Placebo ABBV-0805

Sponsor

AbbVie